Lila G. Glotfelty

Gastroenterology

3300 Gallows Rd
Gastroenterology Dept
Falls Church, VA 22042

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.

Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 196-Week Results from the KEEPsAKE 1 and KEEPsAKE 2 Randomized Clinical Trials.

Journal: Rheumatology and therapy

Published: June 18, 2025

Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results.

Dupilumab Improves Histopathologic Features in Patients With Eosinophilic Esophagitis: LIBERTY EoE TREET Study Results.

Journal: Gastro hep advances

Published: September 05, 2024

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.

Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.

Journal: The New England journal of medicine

Published: June 26, 2024

Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response.

Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response.

Journal: Clinical and translational gastroenterology

Published: June 11, 2024

Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis.

Journal: The American journal of gastroenterology

Published: December 13, 2023

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Journal: The lancet. Gastroenterology & hepatology

Published: May 15, 2023

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study.

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study.

Journal: Gut

Published: May 09, 2023

The enteric nervous system relays psychological stress to intestinal inflammation.

The enteric nervous system relays psychological stress to intestinal inflammation.

Journal: Cell

Published: July 28, 2022

Small molecules, big effects: microbial metabolites in intestinal immunity.

Small molecules, big effects: microbial metabolites in intestinal immunity.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: April 07, 2020

The Microbiome as a Circadian Coordinator of Metabolism.

The Microbiome as a Circadian Coordinator of Metabolism.

Journal: Endocrinology

Published: January 11, 2020

Microtubules are required for efficient epithelial tight junction homeostasis and restoration.

Microtubules are required for efficient epithelial tight junction homeostasis and restoration.

Journal: American journal of physiology. Cell physiology

Published: June 13, 2014

Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.

Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration.

Journal: Cellular microbiology

Published: July 28, 2013

Showing 1-12 of 13

Last Updated: 09/26/2026